Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Generics
Baxter International and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle Federal Trade Commission charges that Baxter’s proposed $625 million acquisition of Claris Injectables business of the Indian parent company is anticompetitive. 21 July 2017
Generics
Medicure, a specialty pharma focused on the development and commercialization of therapeutics for the US hospital market, has exercised an option to snap up additional interests in Apicore, the New Jersey-based API developer and manufacturer. 11 July 2017
Generics
Bain Capital and Cinven, through their Nidda Healthcare unit, have been cleared by German regulators to submit a renewed binding voluntary public takeover offer for all outstanding shares of Stada Arzneimittel, further to its previous bid failing to gain adequate shareholder support. 11 July 2017
Generics
Ireland-incorporated Endo International (Nasdaq: ENDP) has entered into a definitive agreement to sell Mexico City based Grupo Farmacéutico SOMAR to private equity firm Advent International. 5 July 2017
Generics
The proposed 5.3 billion euros ($5.9 billion), or 66 euros per share, acquisition of Stada Arzneimittel has failed to gain sufficient shareholder backing to proceed. 27 June 2017
Generics
The Invent Farma/neuraxpharm, a group created by funds advised by private equity firm Apax Partners in August 2016, has made its first acquisition. 22 June 2017
Generics
Chinese drugmaker Shanghai Pharmaceutical has confirmed media reports that it is in discussions with financial investors over a possible bid for German generics drugmaker Stada Arzneimittel. 18 May 2017
Generics
German generic drugmaker Stada Arzneimittel, the subject of a ~$5.6 billion takeover bid by the private equity groups Bain Capital and Cinven reports that group sales for the first-quarter 2017 increased 14% to 566.3 million euros ($615.6 million). 12 May 2017
Generics
German generic drugmaker Stada Arzneimittel says it has now received the full offer document for the company’s acquisition that was announced on April 10, which it believes is acceptable. 3 May 2017
Generics
Japanese generics firm Sawai Pharmaceutical has signed an agreement to purchase the generic pharmaceuticals business of privately-held Upsher-Smith, from its parent, ACOVA. 21 April 2017
Generics
Stada Arzneimittel has made a decision on which of several takeover proposals it favored. 10 April 2017
Generics
Stada Arzneimittel yesterday confirmed current media reports that the expert sessions which were planned as part of the structured bidding process have been postponed based on the decision of the supervisory board. 17 March 2017
Generics
Stada Arzneimittel says it has today received a legally binding offer from Advent International Corp regarding the acquisition of up to 100% of the German generic drugmaker. 23 February 2017
Generics
Stada Arzneimittel has confirmed receipt of another – third - legally non-binding conditional expression of interest regarding a bid for the acquisition of up to 100% of the shares in the company. 20 February 2017
Generics
The executive board of German generic drugmaker Stada Arzneimittel has decided unanimously to start open-minded talks with both potential bidders for the acquisition of up to 100% of the shares in the company. 14 February 2017
Generics
Due to market rumors, German generic drugmaker Stada Arzneimittel (SAZ: Xetra) has confirmed that it has received two legally non-binding expressions of interest regarding a bid for the acquisition of up to 100% of the shares in the company. 13 February 2017
Generics
Chronic therapies, especially anti-diabetic and cardiac care are helping the Indian pharmaceutical market notch up healthy growth figures, reports The Pharma Letter’s India correspondent. 11 January 2017
Generics
USA-based Baxter International has announced the acquisition of an India-based business to accelerate its strategy to become a global leader in the injectables pharmaceutical space. 16 December 2016
Generics
Indian pharmaceutical companies will continue to seek growth through the acquisition of overseas assets over the next 18-24 months, with the aim of deepening their geographic and product diversity, and further increasing their presence in developed and emerging markets, according to a new report. 14 December 2016
Generics
Through its UK subsidiary, German drugmaker Stada Arzneimittel has acquired a family-owned UK based branded product company. 28 November 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze